GBB was awarded the Top 50 Innovative Biotechnology Companies

Created on:2020-12-29 11:22

logo

December 29th,2020 Press Release

 

GBB was awarded the Top 50 Innovative Biotechnology Companies

 

[2020/12/3, Dongguan]On December 23, 2020, the 3rd Guangdong-Hong Kong-Macao-Greater Bay Area Biotechnology Innovation Enterprise Top 50 Competition, which lasted for nearly half a year, was successfully concluded, and Great Bay Bio was awarded as the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Area and the title of "Pioneer Enterprise".

Organized by ZDVC RESEARCH and KPMG China and hosted by Guangdong Medical Valley, the event aims to discover the future unicorns of biotechnology in the Greater Bay Area and give a boost to the overall biotechnology industry in this area. Great Bay Bio has pioneered the application of artificial intelligence biotechnology in several R&D steps of biopharmaceuticals, and was successfully selected as one of the top 50 biotech innovation enterprises in Guangdong, Hong Kong and Macau, and awarded the title of "Pioneer Enterprise".

Dr. Sean Deng, Director of Intelligent Biologics of Great Bay Bio, said, "the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Award has greatly promoted the cooperation among the three regions and the development of biotechnology innovation in the Greater Bay Area. In the future, Great Bay Bio will continue to take innovation-driven R&D as its core competitiveness to empower biopharmaceutical development and make biopharmaceutical development easier and more efficient.

 

About the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Area

Since June 2018, the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Area Award has been successfully held for three times, which comprehensively evaluates the technological innovation degree and future development prospects of the participating enterprises from three dimensions: leading technology application and breakthrough, commercially availability, valuation and capital market recognition. In recent years, high-quality enterprises in Guangdong, Hong Kong and Macao Greater Bay Area have been highly sought after by the capital market, thus led to strong demand for financing, and the Top 50 enterprises have been performing remarkably, gradually developing into the backbone of the biotechnology industry in the Greater Bay Area.

 

About Great Bay Bio

Great Bay Bio Holdings Limited (GBB for short), headquartered in HKSAR, China, is a biotech company with an ultimate goal of developing innovative biomedical products based on artificial intelligence (AI) technology. We will also apply AI technology to blue ocean markets such as cell therapy, molecular diagnosis and clinical diagnosis.


Our vision is to make global biologics development simpler and more efficient. And we are ambitious to be a tider of the time to do what distinguishes us from the rest of the world. To this end, we capitalize on AI and big data technology to empower biopharmaceutical development by establishing four intelligent technical platforms, which figure prominently in making drug development faster, more cost-effective and lower-risk. 


We have three subsidiaries currently, which are all based in PRC, and an international office in the US is in the pipeline. Our major business office is Dongguan Taili Biotech Co., Ltd., which was founded in 2002 and nestles at a R&D laboratory building with more than 3000 m². Besides, it boasts experienced talents with specific expertise and is equipped with a series of cutting-edge supporting equipment designed for CMC R&D, with which our innovation-driven competiveness can be improved and our customers can be better served.

 

 

For more details, please visit:www.greatbay-bio.com

Contact for business:info@greatbay-bio.com

Contact for media and investment: public@greatbay-bio.com

Home    GBB was awarded the Top 50 Innovative Biotechnology Companies
PV:0
Collect